Status:
UNKNOWN
Assessment of the Increased Risk of Infection Following an Ultratrail
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Collaborating Sponsors:
Jean Monnet University
Hôpital Privé de la Loire- Saint Etienne
Conditions:
Running
Immune Deficiency
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The increase in the practice of running has encouraged a proliferation of studies evaluating the impact of this sport on health. A number of these studies have looked at the influence of endurance eve...
Eligibility Criteria
Inclusion
- \> 18 years
- Participating in a Grand Raid de la Réunion 2023 race (Mascareignes, Trail de Bourbon, Diagonale des Fous)
- Have a companion living under the same roof during the week preceding the race and the 21 days following the race and who agrees to answer the questionnaires
- Do not object to the research
Exclusion
- Do not understand French
- A protected adult (guardianship or curatorship) or under court protection
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT06089174
Start Date
October 1 2023
End Date
December 1 2023
Last Update
October 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Réunion
Saint-Denis, Reunion, 97400